Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_024800.5(NEK11):c.577A>G(p.Thr193Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
NEK11 (HGNC:18593): (NIMA related kinase 11) This gene encodes a member of the never in mitosis gene A family of kinases. The encoded protein localizes to the nucleoli, and may function with NEK2A in the S-phase checkpoint. The encoded protein appears to play roles in DNA replication and response to genotoxic stress. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2009]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.577A>G (p.T193A) alteration is located in exon 7 (coding exon 5) of the NEK11 gene. This alteration results from a A to G substitution at nucleotide position 577, causing the threonine (T) at amino acid position 193 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of glycosylation at Y198 (P = 0.0092);Gain of glycosylation at Y198 (P = 0.0092);Gain of glycosylation at Y198 (P = 0.0092);Gain of glycosylation at Y198 (P = 0.0092);Gain of glycosylation at Y198 (P = 0.0092);Gain of glycosylation at Y198 (P = 0.0092);Gain of glycosylation at Y198 (P = 0.0092);